[1]
T. Abbaz, A. Bendjeddou, and D. Villemin, “DFT study including NBO, NLO response and reactivity descriptor of bis and tris (1,3-dithiole) tetrathiafulvalene”, J. Drug Delivery Ther., vol. 8, no. 3, pp. 96–105, May 2018, doi: 10.22270/jddt.v8i3.1716.